Financial Instruments and Fair Value Measurements (Tables)

3 Months Ended

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Schedule of Cash and Cash Equivalents

The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at December 31, 2020 and September 30, 2020 to the total of these amounts shown on the Company's consolidated statements of cash flows:

(Millions of dollars)	December 31, 2020		September 30, 2020
Cash and equivalents	$	3,248	$	2,825
Restricted cash	199		92
Cash and equivalents and restricted cash	$	3,447	$	2,917